@unpublished{AubrevilleStathonikosDonovanetal.2023, author = {Aubreville, Marc and Stathonikos, Nikolas and Donovan, Taryn and Klopfleisch, Robert and Ganz, Jonathan and Ammeling, Jonas and Wilm, Frauke and Veta, Mitko and Jabari, Samir and Eckstein, Markus and Annuscheit, Jonas and Krumnow, Christian and Bozaba, Engin and Cayir, Sercan and Gu, Hongyan and Chen, Xiang and Jahanifar, Mostafa and Shephard, Adam and Kondo, Satoshi and Kasai, Satoshi and Kotte, Sujatha and Saipradeep, Vangala and Lafarge, Maxime W. and Koelzer, Viktor H. and Wang, Ziyue and Zhang, Yongbing and Yang, Sen and Wang, Xiyue and Breininger, Katharina and Bertram, Christof}, title = {Domain generalization across tumor types, laboratories, and species - Insights from the 2022 edition of the Mitosis Domain Generalization Challenge}, publisher = {arXiv}, address = {Ithaca}, doi = {https://doi.org/10.48550/arXiv.2309.15589}, year = {2023}, abstract = {Recognition of mitotic figures in histologic tumor specimens is highly relevant to patient outcome assessment. This task is challenging for algorithms and human experts alike, with deterioration of algorithmic performance under shifts in image representations. Considerable covariate shifts occur when assessment is performed on different tumor types, images are acquired using different digitization devices, or specimens are produced in different laboratories. This observation motivated the inception of the 2022 challenge on MItosis Domain Generalization (MIDOG 2022). The challenge provided annotated histologic tumor images from six different domains and evaluated the algorithmic approaches for mitotic figure detection provided by nine challenge participants on ten independent domains. Ground truth for mitotic figure detection was established in two ways: a three-expert consensus and an independent, immunohistochemistry-assisted set of labels. This work represents an overview of the challenge tasks, the algorithmic strategies employed by the participants, and potential factors contributing to their success. With an F1 score of 0.764 for the top-performing team, we summarize that domain generalization across various tumor domains is possible with today's deep learning-based recognition pipelines. When assessed against the immunohistochemistry-assisted reference standard, all methods resulted in reduced recall scores, but with only minor changes in the order of participants in the ranking.}, language = {en} } @article{AubrevilleStathonikosDonovanetal.2024, author = {Aubreville, Marc and Stathonikos, Nikolas and Donovan, Taryn and Klopfleisch, Robert and Ammeling, Jonas and Ganz, Jonathan and Wilm, Frauke and Veta, Mitko and Jabari, Samir and Eckstein, Markus and Annuscheit, Jonas and Krumnow, Christian and Bozaba, Engin and Cayir, Sercan and Gu, Hongyan and Chen, Xiang and Jahanifar, Mostafa and Shephard, Adam and Kondo, Satoshi and Kasai, Satoshi and Kotte, Sujatha and Saipradeep, Vangala and Lafarge, Maxime W. and Koelzer, Viktor H. and Wang, Ziyue and Zhang, Yongbing and Yang, Sen and Wang, Xiyue and Breininger, Katharina and Bertram, Christof}, title = {Domain generalization across tumor types, laboratories, and species — Insights from the 2022 edition of the Mitosis Domain Generalization Challenge}, volume = {2024}, pages = {103155}, journal = {Medical Image Analysis}, number = {94}, publisher = {Elsevier}, address = {Amsterdam}, issn = {1361-8423}, doi = {https://doi.org/10.1016/j.media.2024.103155}, year = {2024}, abstract = {Recognition of mitotic figures in histologic tumor specimens is highly relevant to patient outcome assessment. This task is challenging for algorithms and human experts alike, with deterioration of algorithmic performance under shifts in image representations. Considerable covariate shifts occur when assessment is performed on different tumor types, images are acquired using different digitization devices, or specimens are produced in different laboratories. This observation motivated the inception of the 2022 challenge on MItosis Domain Generalization (MIDOG 2022). The challenge provided annotated histologic tumor images from six different domains and evaluated the algorithmic approaches for mitotic figure detection provided by nine challenge participants on ten independent domains. Ground truth for mitotic figure detection was established in two ways: a three-expert majority vote and an independent, immunohistochemistry-assisted set of labels. This work represents an overview of the challenge tasks, the algorithmic strategies employed by the participants, and potential factors contributing to their success. With an score of 0.764 for the top-performing team, we summarize that domain generalization across various tumor domains is possible with today's deep learning-based recognition pipelines. However, we also found that domain characteristics not present in the training set (feline as new species, spindle cell shape as new morphology and a new scanner) led to small but significant decreases in performance. When assessed against the immunohistochemistry-assisted reference standard, all methods resulted in reduced recall scores, with only minor changes in the order of participants in the ranking.}, language = {en} }